Ann Dermatol.  2016 Jun;28(3):402-403. 10.5021/ad.2016.28.3.402.

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis

• Shin S
• Chung KY
• Kim DS

• KMID: 2164657
• DOI: http://doi.org/10.5021/ad.2016.28.3.402

Abstract

No abstract available.

MeSH Terms

Adalimumab*
Arthritis, Rheumatoid*
Necrosis*
Rheumatoid Nodule*
Adalimumab

Figure

• 

  Fig. 1 (A) Multiple various sized erythematous to violaceous subcutaneous nodules on both extensor surfaces of elbows. (B) Biopsy showed dense fibrinoid deposits in deep dermis (H&E, ×100). (C) Biopsy showed palisading granulomas surrounding degenerated connective tissue and fibrin (H&E, ×200).

Reference

1. Scrivo R, Spadaro A, Iagnocco A, Valesini G. Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis. Clin Exp Rheumatol. 2007; 25:117.

2. Wikaningrum R, Highton J, Parker A, Coleman M, Hessian PA, Roberts-Thompson PJ, et al. Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient. Arthritis Rheum. 1998; 41:1783–1797.

3. Cunnane G, Warnock M, Fye KH, Daikh DI. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum. 2002; 47:445–449.

4. van den Berg WB, Joosten LA, Kollias G, van De Loo FA. Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction. Ann Rheum Dis. 1999; 58:Suppl 1. I40–I48.

5. Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, et al. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum. 2000; 43:38–47.